ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/20 | 1,628 | 1,645 | 1,540 | 1,543 | -71 | -4.4% | 619,100 |
2019/05/17 | 1,586 | 1,621 | 1,567 | 1,614 | +39 | +2.5% | 526,000 |
2019/05/16 | 1,520 | 1,578 | 1,507 | 1,575 | +21 | +1.4% | 523,200 |
2019/05/15 | 1,465 | 1,557 | 1,448 | 1,554 | +109 | +7.5% | 737,500 |
2019/05/14 | 1,400 | 1,467 | 1,392 | 1,445 | -18 | -1.2% | 800,800 |
2019/05/13 | 1,510 | 1,512 | 1,432 | 1,463 | -47 | -3.1% | 754,200 |
2019/05/10 | 1,514 | 1,543 | 1,484 | 1,510 | ±0 | ±0% | 628,700 |
2019/05/09 | 1,600 | 1,600 | 1,484 | 1,510 | -71 | -4.5% | 1,130,600 |
2019/05/08 | 1,639 | 1,654 | 1,581 | 1,581 | -92 | -5.5% | 837,500 |
2019/05/07 | 1,634 | 1,735 | 1,626 | 1,673 | +79 | +5% | 1,894,000 |
2019/04/26 | 1,549 | 1,604 | 1,535 | 1,594 | +25 | +1.6% | 631,600 |
2019/04/25 | 1,525 | 1,586 | 1,519 | 1,569 | +54 | +3.6% | 627,300 |
2019/04/24 | 1,585 | 1,633 | 1,513 | 1,515 | -30 | -1.9% | 1,727,000 |
2019/04/23 | 1,515 | 1,568 | 1,492 | 1,545 | +12 | +0.8% | 608,600 |
2019/04/22 | 1,584 | 1,592 | 1,533 | 1,533 | -51 | -3.2% | 629,100 |
2019/04/19 | 1,535 | 1,588 | 1,517 | 1,584 | +34 | +2.2% | 830,100 |
2019/04/18 | 1,680 | 1,717 | 1,545 | 1,550 | -54 | -3.4% | 2,411,900 |
2019/04/17 | 1,578 | 1,619 | 1,558 | 1,604 | +21 | +1.3% | 698,200 |
2019/04/16 | 1,600 | 1,623 | 1,576 | 1,583 | -18 | -1.1% | 544,000 |
2019/04/15 | 1,577 | 1,601 | 1,533 | 1,601 | +8 | +0.5% | 753,000 |
2019/04/12 | 1,593 | 1,742 | 1,548 | 1,593 | -8 | -0.5% | 2,824,800 |
2019/04/11 | 1,634 | 1,644 | 1,565 | 1,601 | -22 | -1.4% | 714,200 |
2019/04/10 | 1,619 | 1,653 | 1,603 | 1,623 | +21 | +1.3% | 784,800 |
2019/04/09 | 1,645 | 1,659 | 1,572 | 1,602 | -12 | -0.7% | 794,400 |
2019/04/08 | 1,612 | 1,687 | 1,590 | 1,614 | -29 | -1.8% | 940,600 |
2019/04/05 | 1,595 | 1,671 | 1,595 | 1,643 | +40 | +2.5% | 1,210,800 |
2019/04/04 | 1,587 | 1,630 | 1,547 | 1,603 | +28 | +1.8% | 792,400 |
2019/04/03 | 1,598 | 1,640 | 1,565 | 1,575 | -12 | -0.8% | 901,500 |
2019/04/02 | 1,678 | 1,681 | 1,525 | 1,587 | -108 | -6.4% | 1,475,000 |
2019/04/01 | 1,729 | 1,736 | 1,689 | 1,695 | -26 | -1.5% | 530,300 |
2019/03/29 | 1,750 | 1,757 | 1,700 | 1,721 | -5 | -0.3% | 525,800 |
2019/03/28 | 1,771 | 1,825 | 1,706 | 1,726 | -5 | -0.3% | 1,252,500 |
2019/03/27 | 1,697 | 1,741 | 1,675 | 1,731 | +34 | +2% | 808,400 |
2019/03/26 | 1,780 | 1,781 | 1,685 | 1,697 | -53 | -3% | 1,027,600 |
2019/03/25 | 1,672 | 1,789 | 1,662 | 1,750 | +8 | +0.5% | 1,335,300 |
2019/03/22 | 1,801 | 1,843 | 1,720 | 1,742 | -96 | -5.2% | 1,690,400 |
2019/03/20 | 1,911 | 1,932 | 1,837 | 1,838 | -92 | -4.8% | 1,408,200 |
2019/03/19 | 1,992 | 2,017 | 1,902 | 1,930 | -68 | -3.4% | 1,502,100 |
2019/03/18 | 1,982 | 2,042 | 1,960 | 1,998 | +56 | +2.9% | 1,910,800 |
2019/03/15 | 2,001 | 2,032 | 1,934 | 1,942 | -63 | -3.1% | 1,496,600 |
2019/03/14 | 2,050 | 2,064 | 1,999 | 2,005 | -24 | -1.2% | 1,081,100 |
2019/03/13 | 1,987 | 2,069 | 1,969 | 2,029 | +15 | +0.7% | 2,822,700 |
2019/03/12 | 1,948 | 2,176 | 1,945 | 2,014 | +123 | +6.5% | 7,549,800 |
2019/03/11 | 1,886 | 1,925 | 1,800 | 1,891 | -31 | -1.6% | 2,587,700 |
2019/03/08 | 1,955 | 1,995 | 1,904 | 1,922 | -73 | -3.7% | 2,359,300 |
2019/03/07 | 1,897 | 2,051 | 1,887 | 1,995 | +65 | +3.4% | 3,482,700 |
2019/03/06 | 1,991 | 2,018 | 1,912 | 1,930 | -48 | -2.4% | 1,345,900 |
2019/03/05 | 1,945 | 1,985 | 1,886 | 1,978 | +14 | +0.7% | 1,697,700 |
2019/03/04 | 1,970 | 2,004 | 1,909 | 1,964 | +10 | +0.5% | 2,153,900 |
2019/03/01 | 2,041 | 2,113 | 1,932 | 1,954 | +13 | +0.7% | 5,392,600 |
1351~
1400
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム